Sodium Chloride Symporter Inhibitors
"Sodium Chloride Symporter Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that inhibit SODIUM CHLORIDE SYMPORTERS. They act as DIURETICS. Excess use is associated with HYPOKALEMIA.
| Descriptor ID |
D049993
|
| MeSH Number(s) |
D27.505.519.562.812 D27.505.696.560.500.863
|
| Concept/Terms |
Diuretics, Thiazide- Diuretics, Thiazide
- Thiazide Diuretics
- Benzothiadiazine Diuretics
- Diuretics, Benzothiadiazine
|
Below are MeSH descriptors whose meaning is more general than "Sodium Chloride Symporter Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Sodium Chloride Symporter Inhibitors".
This graph shows the total number of publications written about "Sodium Chloride Symporter Inhibitors" by people in this website by year, and whether "Sodium Chloride Symporter Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 0 | 5 | 5 |
| 2019 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Sodium Chloride Symporter Inhibitors" by people in Profiles.
-
Renin-Angiotensin Aldosterone System Inhibitors in Primary Prevention and COVID-19. J Am Heart Assoc. 2021 08 03; 10(15):e021154.
-
Renin-angiotensin-aldosterone system inhibitors and SARS-CoV-2 infection: an analysis from the veteran's affairs healthcare system. Am Heart J. 2021 10; 240:46-57.
-
Hypertension, medications, and risk of severe COVID-19: A Massachusetts community-based observational study. J Clin Hypertens (Greenwich). 2021 01; 23(1):21-27.
-
Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19. N Engl J Med. 2020 06 18; 382(25):2441-2448.
-
Blood pressure and low-density lipoprotein cholesterol control status in Chinese hypertensive dyslipidemia patients during lipid-lowering therapy. Lipids Health Dis. 2019 Jan 29; 18(1):32.
-
Association of Hydrochlorothiazide Use and Risk of Malignant Melanoma. JAMA Intern Med. 2018 08 01; 178(8):1120-1122.
-
Fixed-dose combination antihypertensive medications, adherence, and clinical outcomes: A population-based retrospective cohort study. PLoS Med. 2018 06; 15(6):e1002584.
-
Effect of antihypertensive treatment on 24-h blood pressure variability: pooled individual data analysis of ambulatory blood pressure monitoring studies based on olmesartan mono or combination treatment. J Hypertens. 2018 04; 36(4):720-733.
-
Sex differences in antihypertensive treatment in France among 17 856 patients in a tertiary hypertension unit. J Hypertens. 2018 04; 36(4):939-946.
-
Type 2 Diabetes and Thiazide Diuretics. Curr Diab Rep. 2018 02 05; 18(2):6.